Does Managed Care Fuel Pharmaceutical Industry Growth? Michael D. MurrayFrank W. Deardorff Current Opinion 17 September 2012 Pages: 341 - 348
Mega-Mergers in the Pharmaceutical Industry Alain Li Wan Po Current Opinion 17 September 2012 Pages: 349 - 355
The Problem of Protocol Driven Costs in Pharmacoeconomic Analysis Douglas CoyleKaren M. Lee Leading Article 17 September 2012 Pages: 357 - 363
A Review of the Economics of the Prevention and Control of Rabies Martin I. MeltzerCharles E. Rupprecht Review Article 17 September 2012 Pages: 365 - 383
Economic Impact of Aminoglycoside Toxicity and its Prevention Through Therapeutic Drug Monitoring Richard L. SlaughterDiane M. Cappelletty Review Article 17 September 2012 Pages: 385 - 394
The Burden of Illness of Hypopituitary Adults with Growth Hormone Deficiency Leona Hakkaart-van RoijenAlbert BeckersFrans F. H. Rutten Original Research Article 17 September 2012 Pages: 395 - 403
A Method to Select an Instrument for Measurement of HR-QOL for Cross-Cultural Adaptation Applied to Dermatology Adolfo Ga de TiedraJoan MercadalRafael Lozano Original Research Article 17 September 2012 Pages: 405 - 422
Threshold Analysis of Helicobacter pylori Therapy Amnon Sonnenberg Original Research Article 17 September 2012 Pages: 423 - 432
Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France Mark NuijtenLionel HadjadjebaJohn van den Berg Original Research Article 17 September 2012 Pages: 433 - 445
Docetaxel Harriet M. LambLynda R. Wiseman Adis Pharmacoeconomic Drug Evaluation 17 September 2012 Pages: 447 - 459